nodes	percent_of_prediction	percent_of_DWPC	metapath
Octreotide—thymus cancer—thyroid cancer	0.858	1	CtDrD
Octreotide—SSTR1—Peptide GPCRs—TSHR—thyroid cancer	0.00128	0.026	CbGpPWpGaD
Octreotide—SSTR5—Peptide GPCRs—TSHR—thyroid cancer	0.00114	0.0231	CbGpPWpGaD
Octreotide—SSTR1—SIDS Susceptibility Pathways—RET—thyroid cancer	0.00112	0.0228	CbGpPWpGaD
Octreotide—SSTR2—Peptide GPCRs—TSHR—thyroid cancer	0.00105	0.0213	CbGpPWpGaD
Octreotide—SSTR1—SIDS Susceptibility Pathways—THRB—thyroid cancer	0.00104	0.0212	CbGpPWpGaD
Octreotide—SSTR2—SIDS Susceptibility Pathways—RET—thyroid cancer	0.00092	0.0187	CbGpPWpGaD
Octreotide—SSTR4—GPCR ligand binding—CALCB—thyroid cancer	0.000915	0.0186	CbGpPWpGaD
Octreotide—SSTR2—SIDS Susceptibility Pathways—THRB—thyroid cancer	0.000855	0.0174	CbGpPWpGaD
Octreotide—SSTR1—SIDS Susceptibility Pathways—PRKAR1A—thyroid cancer	0.000694	0.0141	CbGpPWpGaD
Octreotide—SSTR3—GPCR ligand binding—CALCB—thyroid cancer	0.000694	0.0141	CbGpPWpGaD
Octreotide—SSTR1—GPCR ligand binding—CALCB—thyroid cancer	0.000665	0.0135	CbGpPWpGaD
Octreotide—SSTR4—Peptide ligand-binding receptors—SST—thyroid cancer	0.000645	0.0131	CbGpPWpGaD
Octreotide—SSTR5—GPCR ligand binding—CALCB—thyroid cancer	0.00059	0.012	CbGpPWpGaD
Octreotide—SSTR2—SIDS Susceptibility Pathways—PRKAR1A—thyroid cancer	0.000568	0.0115	CbGpPWpGaD
Octreotide—SSTR4—Class A/1 (Rhodopsin-like receptors)—TSHR—thyroid cancer	0.000556	0.0113	CbGpPWpGaD
Octreotide—SSTR1—SIDS Susceptibility Pathways—SST—thyroid cancer	0.000549	0.0111	CbGpPWpGaD
Octreotide—SSTR2—GPCR ligand binding—CALCB—thyroid cancer	0.000544	0.011	CbGpPWpGaD
Octreotide—SSTR4—G alpha (i) signalling events—SST—thyroid cancer	0.000544	0.011	CbGpPWpGaD
Octreotide—SSTR4—GPCR downstream signaling—CALCB—thyroid cancer	0.000517	0.0105	CbGpPWpGaD
Octreotide—SSTR3—Peptide ligand-binding receptors—SST—thyroid cancer	0.000489	0.00992	CbGpPWpGaD
Octreotide—SSTR4—head—thyroid cancer	0.000477	0.298	CbGeAlD
Octreotide—SSTR4—Signaling by GPCR—CALCB—thyroid cancer	0.00047	0.00953	CbGpPWpGaD
Octreotide—SSTR1—Peptide ligand-binding receptors—SST—thyroid cancer	0.000469	0.00951	CbGpPWpGaD
Octreotide—SSTR2—SIDS Susceptibility Pathways—SST—thyroid cancer	0.000449	0.00912	CbGpPWpGaD
Octreotide—SSTR4—Class A/1 (Rhodopsin-like receptors)—SST—thyroid cancer	0.000433	0.00878	CbGpPWpGaD
Octreotide—SSTR4—GPCR ligand binding—TSHR—thyroid cancer	0.000424	0.0086	CbGpPWpGaD
Octreotide—SSTR3—Class A/1 (Rhodopsin-like receptors)—TSHR—thyroid cancer	0.000422	0.00856	CbGpPWpGaD
Octreotide—SSTR5—Peptide ligand-binding receptors—SST—thyroid cancer	0.000416	0.00844	CbGpPWpGaD
Octreotide—SSTR3—G alpha (i) signalling events—SST—thyroid cancer	0.000412	0.00837	CbGpPWpGaD
Octreotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—TSHR—thyroid cancer	0.000404	0.00821	CbGpPWpGaD
Octreotide—SSTR1—G alpha (i) signalling events—SST—thyroid cancer	0.000395	0.00803	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—CALCB—thyroid cancer	0.000392	0.00796	CbGpPWpGaD
Octreotide—SSTR3—head—thyroid cancer	0.000389	0.243	CbGeAlD
Octreotide—SSTR2—Peptide ligand-binding receptors—SST—thyroid cancer	0.000384	0.00779	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—CALCB—thyroid cancer	0.000376	0.00763	CbGpPWpGaD
Octreotide—SSTR4—GPCR ligand binding—PTCH1—thyroid cancer	0.00036	0.00731	CbGpPWpGaD
Octreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—TSHR—thyroid cancer	0.000359	0.00728	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—CALCB—thyroid cancer	0.000356	0.00722	CbGpPWpGaD
Octreotide—SSTR5—G alpha (i) signalling events—SST—thyroid cancer	0.000351	0.00712	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—CALCB—thyroid cancer	0.000341	0.00693	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—CALCB—thyroid cancer	0.000333	0.00676	CbGpPWpGaD
Octreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—TSHR—thyroid cancer	0.000331	0.00672	CbGpPWpGaD
Octreotide—SSTR1—SIDS Susceptibility Pathways—HIF1A—thyroid cancer	0.00033	0.00669	CbGpPWpGaD
Octreotide—SSTR4—GPCR ligand binding—SST—thyroid cancer	0.000329	0.00669	CbGpPWpGaD
Octreotide—SSTR3—Class A/1 (Rhodopsin-like receptors)—SST—thyroid cancer	0.000328	0.00666	CbGpPWpGaD
Octreotide—SSTR2—G alpha (i) signalling events—SST—thyroid cancer	0.000324	0.00657	CbGpPWpGaD
Octreotide—SSTR3—GPCR ligand binding—TSHR—thyroid cancer	0.000321	0.00652	CbGpPWpGaD
Octreotide—SSTR4—GPCR ligand binding—CALCA—thyroid cancer	0.000317	0.00644	CbGpPWpGaD
Octreotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—SST—thyroid cancer	0.000314	0.00638	CbGpPWpGaD
Octreotide—SSTR1—GPCR ligand binding—TSHR—thyroid cancer	0.000308	0.00625	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—CALCB—thyroid cancer	0.000308	0.00624	CbGpPWpGaD
Octreotide—SSTR1—head—thyroid cancer	0.000307	0.192	CbGeAlD
Octreotide—SSTR5—Signaling by GPCR—CALCB—thyroid cancer	0.000303	0.00614	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—CALCB—thyroid cancer	0.000279	0.00567	CbGpPWpGaD
Octreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—SST—thyroid cancer	0.000279	0.00566	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—CALCB—thyroid cancer	0.000277	0.00563	CbGpPWpGaD
Octreotide—SSTR5—GPCR ligand binding—TSHR—thyroid cancer	0.000273	0.00554	CbGpPWpGaD
Octreotide—SSTR3—GPCR ligand binding—PTCH1—thyroid cancer	0.000273	0.00554	CbGpPWpGaD
Octreotide—SSTR2—SIDS Susceptibility Pathways—HIF1A—thyroid cancer	0.00027	0.00548	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—TRIM33—thyroid cancer	0.000263	0.00534	CbGpPWpGaD
Octreotide—SSTR1—GPCR ligand binding—PTCH1—thyroid cancer	0.000262	0.00531	CbGpPWpGaD
Octreotide—SSTR2—head—thyroid cancer	0.000261	0.163	CbGeAlD
Octreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—SST—thyroid cancer	0.000257	0.00522	CbGpPWpGaD
Octreotide—SSTR2—GPCR ligand binding—TSHR—thyroid cancer	0.000252	0.00511	CbGpPWpGaD
Octreotide—SSTR3—GPCR ligand binding—SST—thyroid cancer	0.00025	0.00507	CbGpPWpGaD
Octreotide—SSTR3—GPCR ligand binding—CALCA—thyroid cancer	0.00024	0.00488	CbGpPWpGaD
Octreotide—SSTR4—GPCR downstream signaling—TSHR—thyroid cancer	0.000239	0.00486	CbGpPWpGaD
Octreotide—SSTR1—GPCR ligand binding—SST—thyroid cancer	0.000239	0.00486	CbGpPWpGaD
Octreotide—SSTR5—GPCR ligand binding—PTCH1—thyroid cancer	0.000232	0.00471	CbGpPWpGaD
Octreotide—SSTR1—GPCR ligand binding—CALCA—thyroid cancer	0.00023	0.00468	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—TSHR—thyroid cancer	0.000217	0.00441	CbGpPWpGaD
Octreotide—SSTR2—GPCR ligand binding—PTCH1—thyroid cancer	0.000214	0.00435	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—PRKAR1A—thyroid cancer	0.000214	0.00434	CbGpPWpGaD
Octreotide—SSTR5—GPCR ligand binding—SST—thyroid cancer	0.000212	0.00431	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CALCB—thyroid cancer	0.00021	0.00427	CbGpPWpGaD
Octreotide—SSTR5—GPCR ligand binding—CALCA—thyroid cancer	0.000204	0.00415	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CALCB—thyroid cancer	0.000202	0.00409	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—TRIM33—thyroid cancer	0.000199	0.00405	CbGpPWpGaD
Octreotide—MPO—C-MYB transcription factor network—PTGS2—thyroid cancer	0.000198	0.00402	CbGpPWpGaD
Octreotide—SSTR2—GPCR ligand binding—SST—thyroid cancer	0.000196	0.00398	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—TRIM33—thyroid cancer	0.000191	0.00388	CbGpPWpGaD
Octreotide—MPO—Selenium Micronutrient Network—PTGS2—thyroid cancer	0.000191	0.00388	CbGpPWpGaD
Octreotide—SSTR2—GPCR ligand binding—CALCA—thyroid cancer	0.000189	0.00383	CbGpPWpGaD
Octreotide—SSTR4—GPCR downstream signaling—SST—thyroid cancer	0.000186	0.00378	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—PTCH1—thyroid cancer	0.000185	0.00375	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—TSHR—thyroid cancer	0.000181	0.00368	CbGpPWpGaD
Octreotide—SSTR4—GPCR downstream signaling—CALCA—thyroid cancer	0.000179	0.00364	CbGpPWpGaD
Octreotide—MPO—C-MYB transcription factor network—CCND1—thyroid cancer	0.000179	0.00363	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CALCB—thyroid cancer	0.000179	0.00363	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—TCF7L1—thyroid cancer	0.000175	0.00356	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—TSHR—thyroid cancer	0.000174	0.00353	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—TRIM33—thyroid cancer	0.000169	0.00344	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—SST—thyroid cancer	0.000169	0.00343	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CALCB—thyroid cancer	0.000165	0.00335	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—TSHR—thyroid cancer	0.000165	0.00334	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—CALCA—thyroid cancer	0.000163	0.0033	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—PRKAR1A—thyroid cancer	0.000162	0.00329	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—TSHR—thyroid cancer	0.000158	0.00321	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—TRIM33—thyroid cancer	0.000156	0.00317	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—PRKAR1A—thyroid cancer	0.000155	0.00315	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—TSHR—thyroid cancer	0.000154	0.00313	CbGpPWpGaD
Octreotide—MPO—C-MYB transcription factor network—NRAS—thyroid cancer	0.000154	0.00313	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—CDK1—thyroid cancer	0.000147	0.00299	CbGpPWpGaD
Octreotide—MPO—Folate Metabolism—TP53—thyroid cancer	0.000143	0.0029	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—TSHR—thyroid cancer	0.000142	0.00289	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—SST—thyroid cancer	0.000141	0.00286	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—TSHR—thyroid cancer	0.00014	0.00284	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—PTCH1—thyroid cancer	0.00014	0.00284	CbGpPWpGaD
Octreotide—Decreased appetite—Sorafenib—thyroid cancer	0.000139	0.00152	CcSEcCtD
Octreotide—Thrombophlebitis—Epirubicin—thyroid cancer	0.000139	0.00152	CcSEcCtD
Octreotide—Bladder pain—Doxorubicin—thyroid cancer	0.000138	0.00151	CcSEcCtD
Octreotide—Mouth ulceration—Doxorubicin—thyroid cancer	0.000138	0.00151	CcSEcCtD
Octreotide—Blood alkaline phosphatase increased—Epirubicin—thyroid cancer	0.000138	0.00151	CcSEcCtD
Octreotide—Diabetes mellitus—Epirubicin—thyroid cancer	0.000138	0.00151	CcSEcCtD
Octreotide—SSTR5—Signaling by GPCR—PRKAR1A—thyroid cancer	0.000138	0.0028	CbGpPWpGaD
Octreotide—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.000138	0.00151	CcSEcCtD
Octreotide—Fatigue—Sorafenib—thyroid cancer	0.000138	0.0015	CcSEcCtD
Octreotide—Pain—Sorafenib—thyroid cancer	0.000136	0.00149	CcSEcCtD
Octreotide—Constipation—Sorafenib—thyroid cancer	0.000136	0.00149	CcSEcCtD
Octreotide—SSTR3—GPCR downstream signaling—CALCA—thyroid cancer	0.000136	0.00276	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—SST—thyroid cancer	0.000135	0.00275	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—PTCH1—thyroid cancer	0.000134	0.00273	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—TCF7L1—thyroid cancer	0.000133	0.0027	CbGpPWpGaD
Octreotide—MPO—C-MYB transcription factor network—KRAS—thyroid cancer	0.000133	0.00269	CbGpPWpGaD
Octreotide—Cardiac failure congestive—Epirubicin—thyroid cancer	0.000132	0.00145	CcSEcCtD
Octreotide—Gastrointestinal pain—Sorafenib—thyroid cancer	0.000131	0.00143	CcSEcCtD
Octreotide—SSTR1—GPCR downstream signaling—CALCA—thyroid cancer	0.00013	0.00264	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—TSHR—thyroid cancer	0.000129	0.00262	CbGpPWpGaD
Octreotide—Phlebitis—Doxorubicin—thyroid cancer	0.000129	0.00141	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—TSHR—thyroid cancer	0.000128	0.00261	CbGpPWpGaD
Octreotide—Hot flush—Epirubicin—thyroid cancer	0.000128	0.0014	CcSEcCtD
Octreotide—Thrombophlebitis—Doxorubicin—thyroid cancer	0.000128	0.0014	CcSEcCtD
Octreotide—SSTR3—Signaling by GPCR—SST—thyroid cancer	0.000128	0.0026	CbGpPWpGaD
Octreotide—Blood alkaline phosphatase increased—Doxorubicin—thyroid cancer	0.000128	0.0014	CcSEcCtD
Octreotide—Diabetes mellitus—Doxorubicin—thyroid cancer	0.000128	0.0014	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—TCF7L1—thyroid cancer	0.000128	0.00259	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—PRKAR1A—thyroid cancer	0.000127	0.00258	CbGpPWpGaD
Octreotide—Menopausal symptoms—Epirubicin—thyroid cancer	0.000127	0.00139	CcSEcCtD
Octreotide—Urticaria—Sorafenib—thyroid cancer	0.000127	0.00139	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—PRKAR1A—thyroid cancer	0.000126	0.00257	CbGpPWpGaD
Octreotide—Body temperature increased—Sorafenib—thyroid cancer	0.000126	0.00138	CcSEcCtD
Octreotide—Abdominal pain—Sorafenib—thyroid cancer	0.000126	0.00138	CcSEcCtD
Octreotide—Anaphylactoid reaction—Epirubicin—thyroid cancer	0.000124	0.00136	CcSEcCtD
Octreotide—SSTR3—Signaling by GPCR—CALCA—thyroid cancer	0.000123	0.0025	CbGpPWpGaD
Octreotide—Hypoglycaemia—Epirubicin—thyroid cancer	0.000123	0.00134	CcSEcCtD
Octreotide—SSTR1—Signaling by GPCR—SST—thyroid cancer	0.000123	0.00249	CbGpPWpGaD
Octreotide—Cardiac failure congestive—Doxorubicin—thyroid cancer	0.000122	0.00134	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—MEN1—thyroid cancer	0.000121	0.00245	CbGpPWpGaD
Octreotide—Osteoarthritis—Epirubicin—thyroid cancer	0.00012	0.00131	CcSEcCtD
Octreotide—Gastrointestinal haemorrhage—Epirubicin—thyroid cancer	0.00012	0.00131	CcSEcCtD
Octreotide—Pain in extremity—Epirubicin—thyroid cancer	0.00012	0.00131	CcSEcCtD
Octreotide—SSTR5—GPCR downstream signaling—SST—thyroid cancer	0.00012	0.00244	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—PTCH1—thyroid cancer	0.000119	0.00242	CbGpPWpGaD
Octreotide—Hot flush—Doxorubicin—thyroid cancer	0.000119	0.0013	CcSEcCtD
Octreotide—SSTR1—Signaling by GPCR—CALCA—thyroid cancer	0.000118	0.0024	CbGpPWpGaD
Octreotide—Menopausal symptoms—Doxorubicin—thyroid cancer	0.000118	0.00129	CcSEcCtD
Octreotide—Hypersensitivity—Sorafenib—thyroid cancer	0.000118	0.00129	CcSEcCtD
Octreotide—SSTR5—GPCR downstream signaling—CALCA—thyroid cancer	0.000115	0.00234	CbGpPWpGaD
Octreotide—Anaphylactoid reaction—Doxorubicin—thyroid cancer	0.000115	0.00125	CcSEcCtD
Octreotide—Asthenia—Sorafenib—thyroid cancer	0.000115	0.00125	CcSEcCtD
Octreotide—Hypoglycaemia—Doxorubicin—thyroid cancer	0.000114	0.00124	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—TCF7L1—thyroid cancer	0.000113	0.0023	CbGpPWpGaD
Octreotide—Pruritus—Sorafenib—thyroid cancer	0.000113	0.00123	CcSEcCtD
Octreotide—MPO—C-MYB transcription factor network—HRAS—thyroid cancer	0.000113	0.00229	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—CDK1—thyroid cancer	0.000112	0.00227	CbGpPWpGaD
Octreotide—Dehydration—Epirubicin—thyroid cancer	0.000112	0.00122	CcSEcCtD
Octreotide—Pain in extremity—Doxorubicin—thyroid cancer	0.000111	0.00121	CcSEcCtD
Octreotide—Gastrointestinal haemorrhage—Doxorubicin—thyroid cancer	0.000111	0.00121	CcSEcCtD
Octreotide—Osteoarthritis—Doxorubicin—thyroid cancer	0.000111	0.00121	CcSEcCtD
Octreotide—SSTR2—GPCR downstream signaling—SST—thyroid cancer	0.000111	0.00225	CbGpPWpGaD
Octreotide—Dry skin—Epirubicin—thyroid cancer	0.00011	0.0012	CcSEcCtD
Octreotide—SSTR2—Signaling by GPCR—PTCH1—thyroid cancer	0.00011	0.00223	CbGpPWpGaD
Octreotide—Abdominal pain upper—Epirubicin—thyroid cancer	0.00011	0.0012	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—PTCH1—thyroid cancer	0.000109	0.00222	CbGpPWpGaD
Octreotide—Diarrhoea—Sorafenib—thyroid cancer	0.000109	0.00119	CcSEcCtD
Octreotide—SSTR5—Signaling by GPCR—SST—thyroid cancer	0.000109	0.00221	CbGpPWpGaD
Octreotide—Nasopharyngitis—Epirubicin—thyroid cancer	0.000107	0.00117	CcSEcCtD
Octreotide—SSTR1—Signaling by GPCR—CDK1—thyroid cancer	0.000107	0.00217	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—CALCA—thyroid cancer	0.000107	0.00216	CbGpPWpGaD
Octreotide—Gastritis—Epirubicin—thyroid cancer	0.000106	0.00116	CcSEcCtD
Octreotide—Muscular weakness—Epirubicin—thyroid cancer	0.000106	0.00116	CcSEcCtD
Octreotide—Dizziness—Sorafenib—thyroid cancer	0.000106	0.00115	CcSEcCtD
Octreotide—SSTR5—Signaling by GPCR—CALCA—thyroid cancer	0.000105	0.00213	CbGpPWpGaD
Octreotide—Abdominal distension—Epirubicin—thyroid cancer	0.000104	0.00114	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—TCF7L1—thyroid cancer	0.000104	0.00212	CbGpPWpGaD
Octreotide—Influenza—Epirubicin—thyroid cancer	0.000104	0.00113	CcSEcCtD
Octreotide—Asthma—Epirubicin—thyroid cancer	0.000104	0.00113	CcSEcCtD
Octreotide—Dehydration—Doxorubicin—thyroid cancer	0.000103	0.00113	CcSEcCtD
Octreotide—Dry skin—Doxorubicin—thyroid cancer	0.000102	0.00111	CcSEcCtD
Octreotide—Pancreatitis—Epirubicin—thyroid cancer	0.000102	0.00111	CcSEcCtD
Octreotide—Vomiting—Sorafenib—thyroid cancer	0.000101	0.00111	CcSEcCtD
Octreotide—Abdominal pain upper—Doxorubicin—thyroid cancer	0.000101	0.00111	CcSEcCtD
Octreotide—Rash—Sorafenib—thyroid cancer	0.000101	0.0011	CcSEcCtD
Octreotide—SSTR2—Signaling by GPCR—SST—thyroid cancer	0.000101	0.00204	CbGpPWpGaD
Octreotide—Dermatitis—Sorafenib—thyroid cancer	0.000101	0.0011	CcSEcCtD
Octreotide—Headache—Sorafenib—thyroid cancer	0.0001	0.00109	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—SST—thyroid cancer	9.99e-05	0.00203	CbGpPWpGaD
Octreotide—Bronchitis—Epirubicin—thyroid cancer	9.97e-05	0.00109	CcSEcCtD
Octreotide—Nasopharyngitis—Doxorubicin—thyroid cancer	9.93e-05	0.00109	CcSEcCtD
Octreotide—MPO—head—thyroid cancer	9.89e-05	0.0617	CbGeAlD
Octreotide—Gastritis—Doxorubicin—thyroid cancer	9.83e-05	0.00107	CcSEcCtD
Octreotide—Muscular weakness—Doxorubicin—thyroid cancer	9.79e-05	0.00107	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—TSHR—thyroid cancer	9.73e-05	0.00198	CbGpPWpGaD
Octreotide—Dysuria—Epirubicin—thyroid cancer	9.7e-05	0.00106	CcSEcCtD
Octreotide—SSTR2—Signaling by GPCR—CALCA—thyroid cancer	9.68e-05	0.00196	CbGpPWpGaD
Octreotide—Abdominal distension—Doxorubicin—thyroid cancer	9.66e-05	0.00106	CcSEcCtD
Octreotide—Upper respiratory tract infection—Epirubicin—thyroid cancer	9.64e-05	0.00105	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—CALCA—thyroid cancer	9.61e-05	0.00195	CbGpPWpGaD
Octreotide—Influenza—Doxorubicin—thyroid cancer	9.6e-05	0.00105	CcSEcCtD
Octreotide—Asthma—Doxorubicin—thyroid cancer	9.6e-05	0.00105	CcSEcCtD
Octreotide—Pollakiuria—Epirubicin—thyroid cancer	9.58e-05	0.00105	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—PRKAR1A—thyroid cancer	9.58e-05	0.00194	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—CDK1—thyroid cancer	9.49e-05	0.00193	CbGpPWpGaD
Octreotide—Nausea—Sorafenib—thyroid cancer	9.48e-05	0.00104	CcSEcCtD
Octreotide—Weight increased—Epirubicin—thyroid cancer	9.44e-05	0.00103	CcSEcCtD
Octreotide—Pancreatitis—Doxorubicin—thyroid cancer	9.41e-05	0.00103	CcSEcCtD
Octreotide—Weight decreased—Epirubicin—thyroid cancer	9.38e-05	0.00103	CcSEcCtD
Octreotide—Hyperglycaemia—Epirubicin—thyroid cancer	9.36e-05	0.00102	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—TSHR—thyroid cancer	9.33e-05	0.00189	CbGpPWpGaD
Octreotide—Pneumonia—Epirubicin—thyroid cancer	9.3e-05	0.00102	CcSEcCtD
Octreotide—Drowsiness—Epirubicin—thyroid cancer	9.25e-05	0.00101	CcSEcCtD
Octreotide—Bronchitis—Doxorubicin—thyroid cancer	9.23e-05	0.00101	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—PRKAR1A—thyroid cancer	9.18e-05	0.00186	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—MEN1—thyroid cancer	9.15e-05	0.00186	CbGpPWpGaD
Octreotide—Neuropathy peripheral—Epirubicin—thyroid cancer	9.07e-05	0.000991	CcSEcCtD
Octreotide—Jaundice—Epirubicin—thyroid cancer	9.01e-05	0.000985	CcSEcCtD
Octreotide—Conjunctivitis—Epirubicin—thyroid cancer	8.99e-05	0.000983	CcSEcCtD
Octreotide—Urinary tract infection—Epirubicin—thyroid cancer	8.99e-05	0.000983	CcSEcCtD
Octreotide—Dysuria—Doxorubicin—thyroid cancer	8.97e-05	0.000981	CcSEcCtD
Octreotide—Upper respiratory tract infection—Doxorubicin—thyroid cancer	8.92e-05	0.000975	CcSEcCtD
Octreotide—Pollakiuria—Doxorubicin—thyroid cancer	8.87e-05	0.000969	CcSEcCtD
Octreotide—Haematuria—Epirubicin—thyroid cancer	8.82e-05	0.000964	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—MEN1—thyroid cancer	8.77e-05	0.00178	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—CDK1—thyroid cancer	8.76e-05	0.00178	CbGpPWpGaD
Octreotide—Hepatobiliary disease—Epirubicin—thyroid cancer	8.75e-05	0.000956	CcSEcCtD
Octreotide—Weight increased—Doxorubicin—thyroid cancer	8.73e-05	0.000955	CcSEcCtD
Octreotide—Epistaxis—Epirubicin—thyroid cancer	8.72e-05	0.000954	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—CDK1—thyroid cancer	8.7e-05	0.00177	CbGpPWpGaD
Octreotide—Weight decreased—Doxorubicin—thyroid cancer	8.68e-05	0.000949	CcSEcCtD
Octreotide—Sinusitis—Epirubicin—thyroid cancer	8.68e-05	0.000949	CcSEcCtD
Octreotide—Hyperglycaemia—Doxorubicin—thyroid cancer	8.66e-05	0.000946	CcSEcCtD
Octreotide—Pneumonia—Doxorubicin—thyroid cancer	8.61e-05	0.000941	CcSEcCtD
Octreotide—Drowsiness—Doxorubicin—thyroid cancer	8.56e-05	0.000935	CcSEcCtD
Octreotide—Bradycardia—Epirubicin—thyroid cancer	8.45e-05	0.000924	CcSEcCtD
Octreotide—Neuropathy peripheral—Doxorubicin—thyroid cancer	8.39e-05	0.000917	CcSEcCtD
Octreotide—Jaundice—Doxorubicin—thyroid cancer	8.34e-05	0.000912	CcSEcCtD
Octreotide—Rhinitis—Epirubicin—thyroid cancer	8.32e-05	0.00091	CcSEcCtD
Octreotide—Urinary tract infection—Doxorubicin—thyroid cancer	8.32e-05	0.000909	CcSEcCtD
Octreotide—Conjunctivitis—Doxorubicin—thyroid cancer	8.32e-05	0.000909	CcSEcCtD
Octreotide—Hepatitis—Epirubicin—thyroid cancer	8.3e-05	0.000908	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—PTCH1—thyroid cancer	8.28e-05	0.00168	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—TSHR—thyroid cancer	8.28e-05	0.00168	CbGpPWpGaD
Octreotide—Hypoaesthesia—Epirubicin—thyroid cancer	8.26e-05	0.000903	CcSEcCtD
Octreotide—Pharyngitis—Epirubicin—thyroid cancer	8.24e-05	0.000901	CcSEcCtD
Octreotide—Oedema peripheral—Epirubicin—thyroid cancer	8.18e-05	0.000894	CcSEcCtD
Octreotide—Haematuria—Doxorubicin—thyroid cancer	8.16e-05	0.000892	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—PRKAR1A—thyroid cancer	8.14e-05	0.00165	CbGpPWpGaD
Octreotide—Hepatobiliary disease—Doxorubicin—thyroid cancer	8.09e-05	0.000885	CcSEcCtD
Octreotide—Epistaxis—Doxorubicin—thyroid cancer	8.07e-05	0.000882	CcSEcCtD
Octreotide—Sinusitis—Doxorubicin—thyroid cancer	8.03e-05	0.000878	CcSEcCtD
Octreotide—Visual impairment—Epirubicin—thyroid cancer	8e-05	0.000875	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—PTCH1—thyroid cancer	7.94e-05	0.00161	CbGpPWpGaD
Octreotide—Bradycardia—Doxorubicin—thyroid cancer	7.82e-05	0.000855	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—MEN1—thyroid cancer	7.78e-05	0.00158	CbGpPWpGaD
Octreotide—Tinnitus—Epirubicin—thyroid cancer	7.74e-05	0.000846	CcSEcCtD
Octreotide—Flushing—Epirubicin—thyroid cancer	7.7e-05	0.000842	CcSEcCtD
Octreotide—Cardiac disorder—Epirubicin—thyroid cancer	7.7e-05	0.000842	CcSEcCtD
Octreotide—Rhinitis—Doxorubicin—thyroid cancer	7.7e-05	0.000842	CcSEcCtD
Octreotide—Hepatitis—Doxorubicin—thyroid cancer	7.68e-05	0.00084	CcSEcCtD
Octreotide—Hypoaesthesia—Doxorubicin—thyroid cancer	7.64e-05	0.000836	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—TSHR—thyroid cancer	7.64e-05	0.00155	CbGpPWpGaD
Octreotide—Pharyngitis—Doxorubicin—thyroid cancer	7.62e-05	0.000833	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—SST—thyroid cancer	7.57e-05	0.00154	CbGpPWpGaD
Octreotide—Oedema peripheral—Doxorubicin—thyroid cancer	7.57e-05	0.000827	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—PRKAR1A—thyroid cancer	7.51e-05	0.00153	CbGpPWpGaD
Octreotide—Immune system disorder—Epirubicin—thyroid cancer	7.5e-05	0.00082	CcSEcCtD
Octreotide—Arrhythmia—Epirubicin—thyroid cancer	7.42e-05	0.000811	CcSEcCtD
Octreotide—Visual impairment—Doxorubicin—thyroid cancer	7.4e-05	0.000809	CcSEcCtD
Octreotide—Alopecia—Epirubicin—thyroid cancer	7.34e-05	0.000802	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—CALCA—thyroid cancer	7.29e-05	0.00148	CbGpPWpGaD
Octreotide—Mental disorder—Epirubicin—thyroid cancer	7.27e-05	0.000795	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—SST—thyroid cancer	7.26e-05	0.00147	CbGpPWpGaD
Octreotide—Malnutrition—Epirubicin—thyroid cancer	7.23e-05	0.00079	CcSEcCtD
Octreotide—Erythema—Epirubicin—thyroid cancer	7.23e-05	0.00079	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—MEN1—thyroid cancer	7.18e-05	0.00146	CbGpPWpGaD
Octreotide—Tinnitus—Doxorubicin—thyroid cancer	7.16e-05	0.000783	CcSEcCtD
Octreotide—Cardiac disorder—Doxorubicin—thyroid cancer	7.13e-05	0.000779	CcSEcCtD
Octreotide—Flushing—Doxorubicin—thyroid cancer	7.13e-05	0.000779	CcSEcCtD
Octreotide—Flatulence—Epirubicin—thyroid cancer	7.12e-05	0.000779	CcSEcCtD
Octreotide—Tension—Epirubicin—thyroid cancer	7.09e-05	0.000775	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—PTCH1—thyroid cancer	7.04e-05	0.00143	CbGpPWpGaD
Octreotide—Nervousness—Epirubicin—thyroid cancer	7.02e-05	0.000767	CcSEcCtD
Octreotide—Back pain—Epirubicin—thyroid cancer	6.99e-05	0.000764	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—NRG1—thyroid cancer	6.99e-05	0.00142	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CALCA—thyroid cancer	6.99e-05	0.00142	CbGpPWpGaD
Octreotide—Muscle spasms—Epirubicin—thyroid cancer	6.95e-05	0.00076	CcSEcCtD
Octreotide—Immune system disorder—Doxorubicin—thyroid cancer	6.94e-05	0.000759	CcSEcCtD
Octreotide—MPO—lymph node—thyroid cancer	6.93e-05	0.0432	CbGeAlD
Octreotide—Arrhythmia—Doxorubicin—thyroid cancer	6.86e-05	0.00075	CcSEcCtD
Octreotide—Vision blurred—Epirubicin—thyroid cancer	6.81e-05	0.000745	CcSEcCtD
Octreotide—Alopecia—Doxorubicin—thyroid cancer	6.79e-05	0.000742	CcSEcCtD
Octreotide—Mental disorder—Doxorubicin—thyroid cancer	6.73e-05	0.000736	CcSEcCtD
Octreotide—Ill-defined disorder—Epirubicin—thyroid cancer	6.71e-05	0.000733	CcSEcCtD
Octreotide—Erythema—Doxorubicin—thyroid cancer	6.69e-05	0.000731	CcSEcCtD
Octreotide—Malnutrition—Doxorubicin—thyroid cancer	6.69e-05	0.000731	CcSEcCtD
Octreotide—Anaemia—Epirubicin—thyroid cancer	6.68e-05	0.00073	CcSEcCtD
Octreotide—Agitation—Epirubicin—thyroid cancer	6.64e-05	0.000726	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—CDK1—thyroid cancer	6.6e-05	0.00134	CbGpPWpGaD
Octreotide—Flatulence—Doxorubicin—thyroid cancer	6.59e-05	0.00072	CcSEcCtD
Octreotide—Tension—Doxorubicin—thyroid cancer	6.56e-05	0.000717	CcSEcCtD
Octreotide—Malaise—Epirubicin—thyroid cancer	6.52e-05	0.000712	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—PTCH1—thyroid cancer	6.49e-05	0.00132	CbGpPWpGaD
Octreotide—Nervousness—Doxorubicin—thyroid cancer	6.49e-05	0.00071	CcSEcCtD
Octreotide—Vertigo—Epirubicin—thyroid cancer	6.49e-05	0.00071	CcSEcCtD
Octreotide—Syncope—Epirubicin—thyroid cancer	6.48e-05	0.000709	CcSEcCtD
Octreotide—Back pain—Doxorubicin—thyroid cancer	6.47e-05	0.000707	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—SST—thyroid cancer	6.44e-05	0.00131	CbGpPWpGaD
Octreotide—Muscle spasms—Doxorubicin—thyroid cancer	6.43e-05	0.000703	CcSEcCtD
Octreotide—Palpitations—Epirubicin—thyroid cancer	6.39e-05	0.000698	CcSEcCtD
Octreotide—Loss of consciousness—Epirubicin—thyroid cancer	6.35e-05	0.000694	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—CDK1—thyroid cancer	6.32e-05	0.00128	CbGpPWpGaD
Octreotide—Cough—Epirubicin—thyroid cancer	6.31e-05	0.000689	CcSEcCtD
Octreotide—Vision blurred—Doxorubicin—thyroid cancer	6.3e-05	0.000689	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—TERT—thyroid cancer	6.27e-05	0.00127	CbGpPWpGaD
Octreotide—Convulsion—Epirubicin—thyroid cancer	6.26e-05	0.000685	CcSEcCtD
Octreotide—Hypertension—Epirubicin—thyroid cancer	6.24e-05	0.000682	CcSEcCtD
Octreotide—Ill-defined disorder—Doxorubicin—thyroid cancer	6.2e-05	0.000678	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—CALCA—thyroid cancer	6.2e-05	0.00126	CbGpPWpGaD
Octreotide—Anaemia—Doxorubicin—thyroid cancer	6.18e-05	0.000676	CcSEcCtD
Octreotide—Arthralgia—Epirubicin—thyroid cancer	6.15e-05	0.000673	CcSEcCtD
Octreotide—Myalgia—Epirubicin—thyroid cancer	6.15e-05	0.000673	CcSEcCtD
Octreotide—Chest pain—Epirubicin—thyroid cancer	6.15e-05	0.000673	CcSEcCtD
Octreotide—Agitation—Doxorubicin—thyroid cancer	6.15e-05	0.000672	CcSEcCtD
Octreotide—Anxiety—Epirubicin—thyroid cancer	6.13e-05	0.00067	CcSEcCtD
Octreotide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	6.11e-05	0.000668	CcSEcCtD
Octreotide—Discomfort—Epirubicin—thyroid cancer	6.08e-05	0.000665	CcSEcCtD
Octreotide—Malaise—Doxorubicin—thyroid cancer	6.03e-05	0.000659	CcSEcCtD
Octreotide—Dry mouth—Epirubicin—thyroid cancer	6.02e-05	0.000658	CcSEcCtD
Octreotide—Vertigo—Doxorubicin—thyroid cancer	6.01e-05	0.000657	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—HIF1A—thyroid cancer	6e-05	0.00122	CbGpPWpGaD
Octreotide—Syncope—Doxorubicin—thyroid cancer	6e-05	0.000656	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—SST—thyroid cancer	5.94e-05	0.00121	CbGpPWpGaD
Octreotide—Palpitations—Doxorubicin—thyroid cancer	5.91e-05	0.000646	CcSEcCtD
Octreotide—Anaphylactic shock—Epirubicin—thyroid cancer	5.9e-05	0.000645	CcSEcCtD
Octreotide—Oedema—Epirubicin—thyroid cancer	5.9e-05	0.000645	CcSEcCtD
Octreotide—Loss of consciousness—Doxorubicin—thyroid cancer	5.88e-05	0.000643	CcSEcCtD
Octreotide—Infection—Epirubicin—thyroid cancer	5.86e-05	0.000641	CcSEcCtD
Octreotide—Cough—Doxorubicin—thyroid cancer	5.84e-05	0.000638	CcSEcCtD
Octreotide—Shock—Epirubicin—thyroid cancer	5.8e-05	0.000634	CcSEcCtD
Octreotide—Convulsion—Doxorubicin—thyroid cancer	5.79e-05	0.000633	CcSEcCtD
Octreotide—Nervous system disorder—Epirubicin—thyroid cancer	5.78e-05	0.000632	CcSEcCtD
Octreotide—Thrombocytopenia—Epirubicin—thyroid cancer	5.77e-05	0.000631	CcSEcCtD
Octreotide—Hypertension—Doxorubicin—thyroid cancer	5.77e-05	0.000631	CcSEcCtD
Octreotide—Tachycardia—Epirubicin—thyroid cancer	5.76e-05	0.000629	CcSEcCtD
Octreotide—Skin disorder—Epirubicin—thyroid cancer	5.73e-05	0.000626	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—CALCA—thyroid cancer	5.72e-05	0.00116	CbGpPWpGaD
Octreotide—Hyperhidrosis—Epirubicin—thyroid cancer	5.7e-05	0.000623	CcSEcCtD
Octreotide—Chest pain—Doxorubicin—thyroid cancer	5.69e-05	0.000622	CcSEcCtD
Octreotide—Arthralgia—Doxorubicin—thyroid cancer	5.69e-05	0.000622	CcSEcCtD
Octreotide—Myalgia—Doxorubicin—thyroid cancer	5.69e-05	0.000622	CcSEcCtD
Octreotide—Anxiety—Doxorubicin—thyroid cancer	5.67e-05	0.00062	CcSEcCtD
Octreotide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	5.65e-05	0.000618	CcSEcCtD
Octreotide—Discomfort—Doxorubicin—thyroid cancer	5.62e-05	0.000615	CcSEcCtD
Octreotide—Anorexia—Epirubicin—thyroid cancer	5.62e-05	0.000615	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—CDK1—thyroid cancer	5.61e-05	0.00114	CbGpPWpGaD
Octreotide—Dry mouth—Doxorubicin—thyroid cancer	5.57e-05	0.000609	CcSEcCtD
Octreotide—Oedema—Doxorubicin—thyroid cancer	5.46e-05	0.000597	CcSEcCtD
Octreotide—Anaphylactic shock—Doxorubicin—thyroid cancer	5.46e-05	0.000597	CcSEcCtD
Octreotide—Infection—Doxorubicin—thyroid cancer	5.42e-05	0.000593	CcSEcCtD
Octreotide—Musculoskeletal discomfort—Epirubicin—thyroid cancer	5.37e-05	0.000587	CcSEcCtD
Octreotide—Shock—Doxorubicin—thyroid cancer	5.37e-05	0.000587	CcSEcCtD
Octreotide—Nervous system disorder—Doxorubicin—thyroid cancer	5.35e-05	0.000585	CcSEcCtD
Octreotide—Thrombocytopenia—Doxorubicin—thyroid cancer	5.34e-05	0.000584	CcSEcCtD
Octreotide—Insomnia—Epirubicin—thyroid cancer	5.33e-05	0.000583	CcSEcCtD
Octreotide—Tachycardia—Doxorubicin—thyroid cancer	5.33e-05	0.000582	CcSEcCtD
Octreotide—Skin disorder—Doxorubicin—thyroid cancer	5.3e-05	0.00058	CcSEcCtD
Octreotide—Paraesthesia—Epirubicin—thyroid cancer	5.3e-05	0.000579	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—NRG1—thyroid cancer	5.29e-05	0.00107	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—NRAS—thyroid cancer	5.28e-05	0.00107	CbGpPWpGaD
Octreotide—Hyperhidrosis—Doxorubicin—thyroid cancer	5.28e-05	0.000577	CcSEcCtD
Octreotide—Dyspnoea—Epirubicin—thyroid cancer	5.26e-05	0.000575	CcSEcCtD
Octreotide—Somnolence—Epirubicin—thyroid cancer	5.24e-05	0.000573	CcSEcCtD
Octreotide—Anorexia—Doxorubicin—thyroid cancer	5.2e-05	0.000569	CcSEcCtD
Octreotide—Dyspepsia—Epirubicin—thyroid cancer	5.19e-05	0.000568	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—CDK1—thyroid cancer	5.18e-05	0.00105	CbGpPWpGaD
Octreotide—Decreased appetite—Epirubicin—thyroid cancer	5.13e-05	0.000561	CcSEcCtD
Octreotide—Gastrointestinal disorder—Epirubicin—thyroid cancer	5.09e-05	0.000557	CcSEcCtD
Octreotide—Fatigue—Epirubicin—thyroid cancer	5.09e-05	0.000556	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—NRG1—thyroid cancer	5.08e-05	0.00103	CbGpPWpGaD
Octreotide—Pain—Epirubicin—thyroid cancer	5.04e-05	0.000551	CcSEcCtD
Octreotide—Constipation—Epirubicin—thyroid cancer	5.04e-05	0.000551	CcSEcCtD
Octreotide—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	4.97e-05	0.000544	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—BRAF—thyroid cancer	4.97e-05	0.00101	CbGpPWpGaD
Octreotide—Insomnia—Doxorubicin—thyroid cancer	4.94e-05	0.00054	CcSEcCtD
Octreotide—Paraesthesia—Doxorubicin—thyroid cancer	4.9e-05	0.000536	CcSEcCtD
Octreotide—Dyspnoea—Doxorubicin—thyroid cancer	4.87e-05	0.000532	CcSEcCtD
Octreotide—Feeling abnormal—Epirubicin—thyroid cancer	4.86e-05	0.000531	CcSEcCtD
Octreotide—Somnolence—Doxorubicin—thyroid cancer	4.85e-05	0.00053	CcSEcCtD
Octreotide—Gastrointestinal pain—Epirubicin—thyroid cancer	4.82e-05	0.000527	CcSEcCtD
Octreotide—Dyspepsia—Doxorubicin—thyroid cancer	4.8e-05	0.000525	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—TERT—thyroid cancer	4.75e-05	0.000965	CbGpPWpGaD
Octreotide—Decreased appetite—Doxorubicin—thyroid cancer	4.74e-05	0.000519	CcSEcCtD
Octreotide—Gastrointestinal disorder—Doxorubicin—thyroid cancer	4.71e-05	0.000515	CcSEcCtD
Octreotide—Fatigue—Doxorubicin—thyroid cancer	4.71e-05	0.000514	CcSEcCtD
Octreotide—Urticaria—Epirubicin—thyroid cancer	4.69e-05	0.000512	CcSEcCtD
Octreotide—Pain—Doxorubicin—thyroid cancer	4.67e-05	0.00051	CcSEcCtD
Octreotide—Constipation—Doxorubicin—thyroid cancer	4.67e-05	0.00051	CcSEcCtD
Octreotide—Abdominal pain—Epirubicin—thyroid cancer	4.66e-05	0.00051	CcSEcCtD
Octreotide—Body temperature increased—Epirubicin—thyroid cancer	4.66e-05	0.00051	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—TERT—thyroid cancer	4.56e-05	0.000925	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—KRAS—thyroid cancer	4.55e-05	0.000923	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—HIF1A—thyroid cancer	4.55e-05	0.000923	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—NRG1—thyroid cancer	4.5e-05	0.000914	CbGpPWpGaD
Octreotide—Feeling abnormal—Doxorubicin—thyroid cancer	4.5e-05	0.000492	CcSEcCtD
Octreotide—Gastrointestinal pain—Doxorubicin—thyroid cancer	4.46e-05	0.000488	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—HIF1A—thyroid cancer	4.36e-05	0.000885	CbGpPWpGaD
Octreotide—Hypersensitivity—Epirubicin—thyroid cancer	4.35e-05	0.000475	CcSEcCtD
Octreotide—Urticaria—Doxorubicin—thyroid cancer	4.34e-05	0.000474	CcSEcCtD
Octreotide—Body temperature increased—Doxorubicin—thyroid cancer	4.31e-05	0.000472	CcSEcCtD
Octreotide—Abdominal pain—Doxorubicin—thyroid cancer	4.31e-05	0.000472	CcSEcCtD
Octreotide—Asthenia—Epirubicin—thyroid cancer	4.23e-05	0.000463	CcSEcCtD
Octreotide—Pruritus—Epirubicin—thyroid cancer	4.17e-05	0.000456	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—NRG1—thyroid cancer	4.15e-05	0.000843	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—TERT—thyroid cancer	4.04e-05	0.00082	CbGpPWpGaD
Octreotide—Diarrhoea—Epirubicin—thyroid cancer	4.04e-05	0.000441	CcSEcCtD
Octreotide—Hypersensitivity—Doxorubicin—thyroid cancer	4.02e-05	0.00044	CcSEcCtD
Octreotide—SSTR3—Signaling by GPCR—NRAS—thyroid cancer	4.01e-05	0.000813	CbGpPWpGaD
Octreotide—Asthenia—Doxorubicin—thyroid cancer	3.92e-05	0.000428	CcSEcCtD
Octreotide—Dizziness—Epirubicin—thyroid cancer	3.9e-05	0.000426	CcSEcCtD
Octreotide—SSTR4—Signaling by GPCR—HRAS—thyroid cancer	3.87e-05	0.000785	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—HIF1A—thyroid cancer	3.87e-05	0.000785	CbGpPWpGaD
Octreotide—Pruritus—Doxorubicin—thyroid cancer	3.86e-05	0.000422	CcSEcCtD
Octreotide—SSTR1—Signaling by GPCR—NRAS—thyroid cancer	3.84e-05	0.000779	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—BRAF—thyroid cancer	3.76e-05	0.000764	CbGpPWpGaD
Octreotide—SSTR4—GPCR downstream signaling—AKT1—thyroid cancer	3.76e-05	0.000763	CbGpPWpGaD
Octreotide—Vomiting—Epirubicin—thyroid cancer	3.75e-05	0.00041	CcSEcCtD
Octreotide—Diarrhoea—Doxorubicin—thyroid cancer	3.73e-05	0.000408	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—TERT—thyroid cancer	3.73e-05	0.000757	CbGpPWpGaD
Octreotide—Rash—Epirubicin—thyroid cancer	3.72e-05	0.000407	CcSEcCtD
Octreotide—Dermatitis—Epirubicin—thyroid cancer	3.72e-05	0.000406	CcSEcCtD
Octreotide—Headache—Epirubicin—thyroid cancer	3.69e-05	0.000404	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—CCND1—thyroid cancer	3.63e-05	0.000736	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—BRAF—thyroid cancer	3.61e-05	0.000733	CbGpPWpGaD
Octreotide—Dizziness—Doxorubicin—thyroid cancer	3.61e-05	0.000395	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—HIF1A—thyroid cancer	3.57e-05	0.000724	CbGpPWpGaD
Octreotide—Nausea—Epirubicin—thyroid cancer	3.5e-05	0.000383	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—PTEN—thyroid cancer	3.5e-05	0.00071	CbGpPWpGaD
Octreotide—Vomiting—Doxorubicin—thyroid cancer	3.47e-05	0.000379	CcSEcCtD
Octreotide—SSTR3—Signaling by GPCR—KRAS—thyroid cancer	3.45e-05	0.0007	CbGpPWpGaD
Octreotide—Rash—Doxorubicin—thyroid cancer	3.44e-05	0.000376	CcSEcCtD
Octreotide—Dermatitis—Doxorubicin—thyroid cancer	3.44e-05	0.000376	CcSEcCtD
Octreotide—Headache—Doxorubicin—thyroid cancer	3.42e-05	0.000374	CcSEcCtD
Octreotide—SSTR4—Signaling by GPCR—AKT1—thyroid cancer	3.41e-05	0.000693	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—NRAS—thyroid cancer	3.41e-05	0.000691	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—KRAS—thyroid cancer	3.3e-05	0.000671	CbGpPWpGaD
Octreotide—Nausea—Doxorubicin—thyroid cancer	3.24e-05	0.000354	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—BRAF—thyroid cancer	3.2e-05	0.00065	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—NRAS—thyroid cancer	3.14e-05	0.000638	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—NRAS—thyroid cancer	3.12e-05	0.000634	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—BRAF—thyroid cancer	2.95e-05	0.0006	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—KRAS—thyroid cancer	2.93e-05	0.000595	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—HRAS—thyroid cancer	2.93e-05	0.000595	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—AKT1—thyroid cancer	2.85e-05	0.000578	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—HRAS—thyroid cancer	2.81e-05	0.00057	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CCND1—thyroid cancer	2.75e-05	0.000558	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—AKT1—thyroid cancer	2.73e-05	0.000554	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—KRAS—thyroid cancer	2.7e-05	0.000549	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—KRAS—thyroid cancer	2.69e-05	0.000545	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—PTEN—thyroid cancer	2.65e-05	0.000538	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CCND1—thyroid cancer	2.63e-05	0.000535	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—AKT1—thyroid cancer	2.59e-05	0.000525	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—PTEN—thyroid cancer	2.54e-05	0.000516	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—HRAS—thyroid cancer	2.49e-05	0.000506	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—AKT1—thyroid cancer	2.48e-05	0.000503	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—AKT1—thyroid cancer	2.42e-05	0.000492	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—TP53—thyroid cancer	2.39e-05	0.000485	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—NRAS—thyroid cancer	2.37e-05	0.00048	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CCND1—thyroid cancer	2.34e-05	0.000474	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—HRAS—thyroid cancer	2.3e-05	0.000467	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—HRAS—thyroid cancer	2.28e-05	0.000464	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—NRAS—thyroid cancer	2.27e-05	0.00046	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—PTEN—thyroid cancer	2.25e-05	0.000458	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—AKT1—thyroid cancer	2.24e-05	0.000454	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—AKT1—thyroid cancer	2.2e-05	0.000447	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CCND1—thyroid cancer	2.16e-05	0.000438	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—PTEN—thyroid cancer	2.08e-05	0.000422	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—KRAS—thyroid cancer	2.04e-05	0.000413	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—AKT1—thyroid cancer	2.03e-05	0.000412	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—AKT1—thyroid cancer	2.02e-05	0.000409	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—NRAS—thyroid cancer	2.01e-05	0.000408	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—KRAS—thyroid cancer	1.95e-05	0.000396	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—NRAS—thyroid cancer	1.86e-05	0.000377	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—TP53—thyroid cancer	1.81e-05	0.000367	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—TP53—thyroid cancer	1.74e-05	0.000352	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—KRAS—thyroid cancer	1.73e-05	0.000351	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—HRAS—thyroid cancer	1.73e-05	0.000351	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—HRAS—thyroid cancer	1.66e-05	0.000337	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—KRAS—thyroid cancer	1.6e-05	0.000324	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—TP53—thyroid cancer	1.54e-05	0.000312	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—AKT1—thyroid cancer	1.53e-05	0.00031	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—HRAS—thyroid cancer	1.47e-05	0.000299	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—AKT1—thyroid cancer	1.47e-05	0.000297	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—TP53—thyroid cancer	1.42e-05	0.000288	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—HRAS—thyroid cancer	1.36e-05	0.000276	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—AKT1—thyroid cancer	1.3e-05	0.000264	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—AKT1—thyroid cancer	1.2e-05	0.000243	CbGpPWpGaD
